RCW 69.51.030
Definitions.
As used in this chapter:
(1) "Cannabis" means all parts of the plant of the genus Cannabis L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin;
(2) "Commission" means the pharmacy quality assurance commission;
(3) "Department" means the department of health; and
(4) "Practitioner" means a physician licensed pursuant to chapter 18.71 or 18.57 RCW.
[ 2022 c 16 § 113; 2013 c 19 § 113; 1989 1st ex.s. c 9 § 438; 1979 c 136 § 3.]
NOTES:
Reviser's note: The definitions in this section have been alphabetized pursuant to RCW 1.08.015(2)(k).
Intent—Finding—2022 c 16: See note following RCW 69.50.101.
Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
Structure Revised Code of Washington
Title 69 - Food, Drugs, Cosmetics, and Poisons
Chapter 69.51 - Controlled Substances Therapeutic Research Act.
69.51.020 - Legislative purpose.
69.51.040 - Controlled substances therapeutic research program.
69.51.050 - Patient qualification review committee.
69.51.060 - Sources and distribution of cannabis.
69.51.080 - Cannabis and related products considered Schedule II substances.